Data as of Aug 29
| -0.03 / -0.52%|
The 7 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 12.00, with a high estimate of 16.00 and a low estimate of 9.00. The median estimate represents a +110.53% increase from the last price of 5.70.
The current consensus among 8 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.